Founded Year
2002Stage
IPO | IPOTotal Raised
$156.13MDate of IPO
9/19/2019Market Cap
0.17BStock Price
9.85About Exagen
Exagen is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, the company's Avise tests are specifically designed to provide objective information to physicians and patients for more accurate, efficient diagnosis and better disease management.
Exagen Headquarter Location
1261 Liberty Way Suite C
Vista, California, 92081,
United States
+1 760 560 1501
Latest Exagen News
Jan 10, 2022
Collaboration to develop novel patented molecular signatures for rheumatoid arthritis biologic therapeutic selection SAN DIEGO, Jan. 09, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, and Queen Mary University of London, announced today the execution of a research collaboration and exclusive license agreement. The collaboration will focus on development and optimization of patent-pending precision … Continue reading "Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement" The post Exagen and Queen Mary University of London Announce Exclusive License and Collaboration Agreement appeared first on Tullis Funds.
Expert Collections containing Exagen
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Exagen is included in 3 Expert Collections, including Medical Devices.
Medical Devices
7,888 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,394 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Biopharma Tech
818 items
Exagen Patents
Exagen has filed 17 patents.
The 3 most popular patent topics include:
- Autoimmune diseases
- Coagulopathies
- Glucocorticoids
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/10/2012 | 11/20/2018 | Autoimmune diseases, Immune system, Immunology, Inflammations, Rheumatology | Grant | |
Application Date | 2/10/2012 | ||||
|---|---|---|---|---|---|
Grant Date | 11/20/2018 | ||||
Title | |||||
Related Topics | Autoimmune diseases, Immune system, Immunology, Inflammations, Rheumatology | ||||
Status | Grant |
